Dr. Dow has over 20 years of experience in infectious disease research and product development, including a strong background in tropical diseases. He co-founded 60P in 2010, where he has been instrumental in advancing drug development, securing FDA approvals, and managing regulatory affairs for products like tafenoquine (Arakoda) for malaria. With a rich history of leadership at the Walter Reed Army Institute of Research, Dr. Dow has developed a keen understanding of the challenges involved ...